Login / Signup

Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 disease.

Christian M ZobelHartmut KühnMaximilian SchreinerWerner WenzelJasper WendtlandCengiz GoekeriLorenz ScheitKlaas OltmannsDominic RauschningMarica GrossegesseNatalie HofmannHubert WirtzSebastian Spethmannnull null
Published in: Virology journal (2024)
 PreBiSeCov: German Clinical Trials Register, DRKS-ID: DRKS00021591, Registered on 27th April 2020.
Keyphrases
  • angiotensin converting enzyme
  • angiotensin ii
  • clinical trial
  • coronavirus disease
  • sars cov
  • genome wide
  • copy number
  • phase ii
  • genome wide identification
  • gene expression
  • open label
  • double blind